Validated antibody with 20 RRID-verified research citations across 1 target. Confirmed for IF, IHC, WB. Reactive in H, M, R.

GFAP (E4L7M) XP® Rabbit mAb

Cell Signaling TechnologyCat# 80788Clone: Clone E4L7M
20citations
Applications
IFIHCWB
Reactivity
HMR
HostRabbit
ClonalityMonoclonal
Research Usage20citations
View on Cell Signaling TechnologyView RRID verification

More GFAP antibodies from other suppliers

Compared on specifications and validation. No paid placements.

gfap Antibody
CUSABIOCat# CSB-PA009369LA01DIL
Validated · ELISA, WB
Applications
ELISAWB
Reactivity
ZebrafishHuman
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
Gfap Antibody
CUSABIOCat# CSB-PA009369LA01RA
Validated · ELISA, WB
Applications
ELISAWB
Reactivity
RatMouse
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
GFAP Antibody
CUSABIOCat# CSB-PA009369LA01HU
Validated · ELISA, WB, IHC
Applications
ELISAWBIHCIF
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
GFAP Antibody
CUSABIOCat# CSB-PA008787
Validated · WB, IHC, IF
Applications
WBIHCIFELISA
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
GFAP Antibody
CUSABIOCat# CSB-PA289722
Validated · ELISA, IHC
Applications
ELISAIHC
Reactivity
HumanMouseRat
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
GFAP Antibody
CUSABIOCat# CSB-PA047116
Validated · ELISA, WB, IF
Applications
ELISAWBIF
Reactivity
HumanRat
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
GFAP Monoclonal Antibody
CUSABIOCat# CSB-MA000216Clone: 13E9
Validated · ELISA, WB
Applications
ELISAWB
Reactivity
RatMouse
HostMouse
ClonalityMonoclonal
View datasheet on CUSABIO
GFAP Monoclonal Antibody
CUSABIOCat# CSB-MA009369A0mClone: 1C91F1
Validated · ELISA, WB, IHC
Applications
ELISAWBIHCIFFC
Reactivity
HumanMouseRat
HostMouse
ClonalityMonoclonal
View datasheet on CUSABIO

+ 39 more GFAP options from other suppliers.

Product verified through the Antibody Registry (RRID). Application and species data from supplier specifications and published research. No paid placements.